medigraphic.com
SPANISH

Medicina & Laboratorio

ISSN 2500-7106 (Electronic)
ISSN 0123-2576 (Print)
Medicina & Laboratorio
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2017, Number 01-02

<< Back Next >>

Medicina & Laboratorio 2017; 23 (01-02)

Chorioamnionitis characterization in patients treated in Hospital Susana Lopez de Valencia (Popayan, Colombia) between june 2013 and june 2014

Verdugo-Muñoz LM, Ortiz-Martinez RA, Angel-Angel GA, Solís-Parra MA, Stephens-Mosquera WS, Vidal-López CO
Full text How to cite this article

Language: Spanish
References: 19
Page: 75-83
PDF size: 418.35 Kb.


Key words:

Pregnancy, postpartum period, chorioamnionitis.

ABSTRACT

Introduction: Chorioamnionitis is the infection of the membranes of the amniotic sac, chorion and amnion. Objetive: To characterize clinally the patients diagnosed with chorioamnionitis who were treated at the hospital Susana López de Valencia in the city of Popayan (Colombia) during June 2013 and June 2014 Methodology: A cross-sectional descriptive study was performed based on records of institutional clinical records with has diagnosis of chorioamnionitis during the established study period. Results: A total of 268 patients were included with an average age between 19 and 34 years old. The most frequent clinical syntomatology associated with chorioamnionitis was premature rupture of membranes (35.82%). Most patients (77.24%) were clinical diagnosed at the postpartum period (up to the first three days postpartum) presenting leukocytosis greater than 15,000/µL (47.83%) and hyperthermic cavity (40.58%). Finally, to establish which symptoms had been presented in conjunction with fever according with Gibbs criteria a cross-variable was performed, which stablishes that during antepartum and postpartum the leukocytosis (68.18% and 76%, respectively) and maternal tachycardia (73% and 76%, respectively) were the most two prevalent symptoms. Conclusions: The indirect prevalence of chorioamnionitis in the study sample was 8.05%. The main risk factor for this disease was the premature rupture of ovary membranes and their diagnosis was made mainly in the postpartum period with the help of Gibbs criteria.


REFERENCES

  1. Sorano S, Goto M, Matsuoka S, Tohyama A, Yamamoto H, Nakamura S, et al. Chorioamnionitis caused by Staphylococcus aureus with intact membranes in a term pregnancy: A case of maternal and fetal septic shock. J Infect Chemother 2016; 22: 261-264.

  2. Johnson CT, Farzin A, Burd I. Current management and long-term outcomes following chorioamnionitis. Obstet Gynecol Clin North Am 2014; 41: 649-669.

  3. Liu Y, Liu Y, Du C, Zhang R, Feng Z, Zhang J. Diagnostic value of amniotic fluid inflammatory biomarkers for subclinical chorioamnionitis. Int J Gynaecol Obstet 2016; 134: 160-164.

  4. Silva S. Infecciones en Ginecología y Obstetricia (ed 2a). Chile: Editorial Mediterraneo; 2010.

  5. Martinelli P, Sarno L, Maruotti GM, Paludetto R. Chorioamnionitis and prematurity: a critical review. J Matern Fetal Neonatal Med 2012; 25 Suppl 4: 29-31.

  6. Espitia-De La Hoz FJ. Diagnóstico y tratamiento de la corioamnionitis clínica. Rev Colomb Obstet Ginecol 2008; 59: 231-237.

  7. Colina MF, Galiano J, Madail A. Corioamnionitis subclínica: correlación histológica- microbiológica y morbilidad neonatal. Rev Obstet Ginecol Venez 2013; 73: 25-32.

  8. Rincón-Ricote MI, Magdaleno-Dans F, Sancha- Naranjo M, Omeñaca-Teres F, González-González A. Corioamnionitis histológica y morbimortalidad neonatal: aproximación al síndrome de respuesta inflamatoria fetal. Rev Chil Obstet Ginecol 2010; 75: 172-178.

  9. Koch MO, Romano MF, Jara ML, Sciangula MD. Corioamnionitis. Rev posgrado VIa Cátedra Med 2008; 180: 21-23.

  10. Arroyave Y, Benavides-Puchana L, Agudelo-Ledezma H, Arcila-Romero D, Bermúdez-Roa J. Corioamnionitits: un reto diagnóstico. Rev Fac Ciencias Salud UNICauca 2013; 15: 17-24.

  11. García-de la Torre JI, Delgado-Rosas A, González- Cantú G. Frecuencia de corioamnionitis histológica en pacientes con ruptura prematura de membranas. Ginecol Obstet Méx 2014; 82: 791-795.

  12. Faneite P, Rivera C, Amato R, Faneite J. Corioamnionitis. Repercusión perinatal. Rev Obstet Ginecol Venez 2010; 70: 233-239.

  13. Gantert M, Been JV, Gavilanes AW, Garnier Y, Zimmermann LJ, Kramer BW. Chorioamnionitis: a multiorgan disease of the fetus? J Perinatol 2010; 30 Suppl: S21-30.

  14. Reyna-Villasmil E, Santos-Bolívar J, Briceño-Pérez C. Infección intraamniótica y corioamnionitis. Rev Latin Perinat 2015; 18: 219-225.

  15. Pinzón-Plata C. Rendimiento de los criterios de Gibbs en el diagnóstico de corioamnionitis histológica. Tesis para optar al título de Especialista en Ginecología y Obstetricia. Bucaramanga, Colombia: Universidad Industrial de Santander; 2010.

  16. Chapman E, Reveiz L, Illanes E, Bonfill Cosp X. Regímenes antibióticos para el tratamiento de la infección intraamniótica. Cochrane Database Syst Rev 2014; 12: CD010976.

  17. Argilagos-Casasayas G, Arañó-Piedra JF, Pérez- Reina M, Morando-Flores D, Hierrezuelo-González G. Impacto maternoperinatal de la corioamnionitis. MEDISAN 2012; 16: 49-55.

  18. Tiufekchieva E. [Intrauterine infection in premature rupture of fetal membranes--dynamics]. Akush Ginekol (Sofiia) 2006; 45: 7-12.

  19. Norte G, Forero I, Troitiño M, Gil-Del Real P, Cisterna O, Vaca I, et al. Correlación entre sepsis neonatal y corioamnionitis clínica e histológica en neonatos a término. Pediátr Panamá 2008; 37: 5-14.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Medicina & Laboratorio. 2017;23